StockData
City Therapeutics, Inc. logo

City Therapeutics, Inc. (CTY) income statement

CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.64−0.86 (-4.91%)

Close on Nov 18, 2026Market cap –P/E –Yield –

City Therapeutics, Inc. income statement

AnnualQuarterlyTTM

This company has not reported income statement data in its XBRL filings.

Ratios

Latest available

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY
–

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?